These results suggest that melanoma represents a unique opportunity as a disease in which two broad therapeutic windows (ERK1/2 addiction and MCL1 addiction) are inter-dependent, with MCL1 addiction only manifest when ERK1/2 signalling is inhibited. The gene discussed is MCL1; the disease is melanoma.